# 1. Financial Performance ## A. Key Figures * **Consolidated Revenue:** **₹1,136 Cr** (Q3 FY26) (–1% YoY) * **EBITDA:** **₹275 Cr** (Q3 FY26) (–6% YoY) ## B. Revenue Trends * **Sharp Segmental Downturn:** Fluorochemicals revenue saw steep double-digit declines amid refrigerant portfolio weakness, while bulk chemicals faced pricing pressure from chloromethanes and caustic soda. * **Subdued Specialty Demand:** Specialty chemicals performance remained soft due to near-term demand headwinds, contributing to overall top-line contraction. * **Strategic Investment:** Company has committed **₹1,700 Cr** to battery chemical assets with a targeted asset turnover of **2x**, signaling long-term positioning in high-growth segments. * **Margin Protection in LiPF6:** Pricing linked to lithium carbonate via formula ensures **stable margins** and reduces customer price volatility, enhancing commercial resilience. ## C. EBITDA Margins * **Profitability Pressure:** EBITDA decline driven by underperformance in refrigerant segment, particularly R-22, R-125, and delayed R-32 ramp-up, weighing on operating leverage. ## D. Working Capital * **Working Capital Target Set:** Management targets **170–180 days**, aligned with stock-and-sell model and early shipping norms, though current levels remain elevated. ## E. Inventory Levels * **Inventory Surge & Drawdown:** Inventory peaked at **201 days** due to pre-emptive stockpiling and external disruptions from holiday season slowdowns and tariffs, now reversing as offtake resumes. * **Active De-stocking Underway:** Company is reducing inventory across domestic and international warehouses, signaling progress toward normalization. --- # 2. Product & Segment Performance ## A. Key Figures * **Fluoropolymer Revenue Growth:** **14%** YoY (+14%) · **-3%** sequentially (-3%) * **Growth Shortfall:** Growth potential reduced by **more than a quarter** from initial projections ## B. Fluoropolymer Growth * **Below-Target Growth:** Solid double-digit YoY expansion in fluoropolymers, but growth fell short of targets due to **tariff policy uncertainty** and **rejected antidumping duties**, which dampened domestic and export demand. * **Market Share Gains:** Company is gaining share in **fluoroelastomers** and other fluoropolymers, driven by **legacy player exits** and advancing customer approvals, despite broader market headwinds. * **Semiconductor & EV Tailwinds:** **PFA demand** is rising on semiconductor recovery and cleanroom investments, while **fluoroelastomer growth** is supported by strong domestic and U.S. auto sales and **tariff reductions**. * **Future-Ready Pipeline:** **PVDF and PTFE binders** are in final qualification, with **PVDF** set for initial commercial supply; **dry electrode tech shift** opens major opportunity for **high-grade PTFE**, where the company has proven capability. ## C. Refrigerant Challenges * **Pricing Pressure Persists:** Refrigerant segment weighed down by **weak R-125 and R-22 prices**, though outlook is improving on rising demand for **R-32 and R-125** and potential expansion into **R-410**. ## D. Battery Chemicals Progress * **Commercial Traction Achieved:** **LiPF6** has entered commercial supply with **repeat orders in Q4 FY26**, backed by approvals from **global OEMs and electrolyte makers**, signaling strong customer confidence. * **Integrated Platform Building:** Battery materials strategy advancing with **binder commercialization expected in H1 FY27**, **ongoing trials in commercial vehicles**, and **strategic backing from IFC and a sovereign fund**, laying foundation for scalable growth. ## E. Specialty Chemicals Mix * **Premiumization Strategy:** **80% of PTFE sales** now in high-performance grades, reflecting deliberate shift from base products to improve realizations; lower suspension-grade volumes are mix-driven, not demand-related. * **Fluorospecialities Deprioritized:** Segment continues only for select products meeting **specific margin thresholds**, with no strategic growth focus amid higher-priority opportunities in fluoropolymers and battery chemicals. --- # 3. Capacity & Production ## A. Key Figures * **R-32 Initial Capacity:** **20,000 tonnes** (phased ramp-up; first phase commissioned Feb) · **30,000 tonnes** targeted by Dec 2027 * **LFP CAPEX:** **$260 million** (first phase only) · **$216 million** greenfield Oman project · **$82 million** sovereign fund investment secured * **Oman Project CAPEX:** Part of **₹6,000 Cr** total battery materials outlay (FY2028 completion) ## B. R-32 Ramp-up * **Delayed but Operational:** R-32 production has commenced after start-up delays, with focus on safety validation; initial phase of **20,000 tonnes** now being gradually ramped up. * **Phased Expansion Confirmed:** Full capacity expansion to **30,000 tonnes** remains on track for completion by December 2027, with second phase timeline aligned to regulatory deadlines. * **Capacity Speculation Clarified:** Management confirmed **32,000 tonnes** is under consideration for future phases, dispelling near-term overcapacity assumptions. ## C. LFP Plant Status * **Commercialization Underway:** LFP plant commissioned and stabilizing; sample dispatches ongoing with **commercial supply expected in coming months** post-qualification. * **LiPF6 Supply Initiated:** LiPF6 product is qualified and in commercial supply, with **binder and electrolyte production scaling toward full utilization**. * **Global Strategy, Limited Disclosure:** First-phase LFP CAPEX supports a globally targeted facility; specific capacity and product details withheld for competitive reasons. ## D. Oman Project Timeline * **On Track, Strategically Positioned:** Oman project embedded within existing ₹6,000 Cr CAPEX plan, targeting **mid to end-2027 commissioning** with **18-month execution timeline**. * **Higher CAPEX, Competitive Total Cost:** Despite elevated upfront costs due to equipment imports, Oman’s **combined CAPEX and Opex remains competitive vs. China**. * **Ecosystem Development Ahead:** While current raw material access (phosphate/lithium) is limited, Oman is building a long-term industrial ecosystem to support future advantages. ## E. Debottlenecking Efforts * **Flexibility & Optimization:** No constraints on shifting from suspension to emulsion production; **debottlenecking initiatives underway** to boost output of higher-margin products. --- # 4. Customer & Market Access ## A. Global Approvals * **Strategic Non-PFA Positioning:** Operates as a **non-PFA supplier**, enabling superior customer access and pricing power versus Chinese peers, whose offerings are more volatile and cost-competitive. ## B. U.S. Market Entry * **C. S. Supply Transition Imminent:** A key U.S. customer has qualified the company as a replacement supplier, with ramp-up expected to begin gradually from **March or April**, pending inventory digestion. * **Global Supply Chain Buildout:** EV subsidiary is establishing an alternate supply chain targeting **U.S., Europe, and India**, though near-term focus remains international due to **immature domestic demand in India**. ## C. EV & ESS Demand * **Structural Growth Tailwinds:** Battery materials segment leverages surging demand from BESS, EVs, data centers, AI/ML infrastructure, and renewable energy transition. * **Supply Gap Advantage:** **Limited non-Chinese LiPF6 capacity** positions the company as a critical de-risking partner for U.S. and European customers seeking **secure, alternative supply chains**. * **Diversified Product Traction:** Strong commercial momentum in **LFP CAM and binders**, with active demand from global customers aiming to reduce reliance on Chinese suppliers. * **Established International Footprint:** Has already secured customers across **D. S. and Europe** in three core product lines, validating go-to-market strategy ahead of India’s market development. ## D. Semiconductor Recovery * **Improved Sentiment & Visibility:** Recent **tariff rationalization** has boosted customer confidence and order transparency, supporting strong fluoropolymer demand outlook. * **Early-Cycle Semiconductor Rebound:** Industry shows signs of recovery with **rising customer demand and higher prices** driven by memory chip shortages, marking a positive shift since年初. --- # 5. Export & Geography Mix ## A. Key Figures * **Commissioned Capacity:** **₹1,700 Cr** of capacity currently operational * R-32 Quota: 20,000 tonnes initial capacity; additional quota available beyond entitlement ## B. U.S. Tariff Impact * **Tariff Relief Catalyst:** Sharp reduction in U.S. tariffs from 50% to 18% expected to restore export competitiveness and reverse volume-realization pressures. * **Global Supply Chain Spillover:** Prior tariff headwinds created ripple effects across regions, compounding operational challenges. ## C. Europe & India Sales * **R-32 Market Expansion:** Strategic push into global and domestic markets, leveraging existing R-125 position to access R-410A blend and standalone R-32 demand. * **Scalable Quota Advantage:** Significant headroom beyond current R-32 allocation supports future export growth. ## D. FTA Advantages * **Oman as Strategic Hub:** FTA access to U.S. and India, combined with **lower energy costs** and **favorable input logistics**, enhances competitiveness vs. Chinese and European peers. ## E. China Diversification * **Global Export Pivot:** Underperforming domestic demand (e.g., electrolytes) accelerates shift toward international markets, particularly the U.S. * **Duty-Free Export Leverage:** Absence of antidumping duties enables redirection of reserved volumes to higher-margin global customers. * **Export-Focused Product Portfolio:** LiPF6, LFP CAM, and fluoropolymer binders prioritized for global sales due to immature domestic battery ecosystem. --- # 6. Risks & Regulatory Factors ## A. Key Figures * **R-22 Production:** **~19,000 tonnes** (CY 2019) · **~32,000 tonnes R-32 equivalent** (65% GWP conversion) ## B. Quota & Regulatory Developments * **R-22 Headwinds:** R-22 business materially impacted by **production quota cuts** and **seasonal demand weakness**, weighing on volumes and profitability. * **R-32 Quota Timeline:** Company has secured access to R-32 quota with **final confirmation deadline by end of current year**, ahead of **December 2027 plant commissioning**. * **Antidumping Setback:** Expected domestic antidumping duties **not approved by Ministry of Finance**, undermining volume growth assumptions and competitive protection. * **2027 Capacity Mandate:** Quota eligibility requires **operational plant capacity by end-CY 2027**, aligning with company’s current project schedule. ## C. Long Qualification Cycles * **Adoption Delays:** Customer qualification processes and **persistent legacy product stockpiles** are slowing transition, though **steady quarterly uptake** is now evident. * **Battery Chemical Hurdles:** **Extended qualification timelines** for EV/ESS applications—especially for critical components—are delaying revenue scale-up. * **PTFE Volume Outlook:** Dry process adoption could boost PTFE demand, but **ramp-up constrained by testing, qualifications, and grade development**. ## D. Tariff Uncertainty * **External Pressures:** Refrigerant segment weakened by **seasonality, Western holiday periods**, and **ongoing U.S. tariff uncertainty**. * **Customer Hesitation:** **Recent tariff announcements and market confusion** have delayed customer transitions to company’s next-gen products. --- # 7. Guidance & Outlook ## A. FY 2027 Revenue View * **Growth Catalysts:** Revenue recovery expected by FY 2027 driven by **tariff rationalization, R-32 production ramp-up**, and **accelerating EV ESS adoption**. * **Export-Led Scaling:** Long-term growth model anchored in **scaling exports**, supported by global supply chain diversification trends. * **Segment Strength:** Fluoropolymers maintain strong fundamentals despite **B. S. tariff headwinds** and temporary industry demand delays. ## C. Capacity Utilization Path * **Utilization Outlook:** Full capacity utilization expected by **FY 2027–2028**, led by LiPF6 revenue in FY 2027 and LFP commercialization from FY 2028. * **Market-Dependent Ramp-Up:** Current utilization remains low; recovery contingent on **broader market demand improvement**. * **Capacity Expansion Flexibility:** Phase II expansion decision remains **market-driven**, with full quota available until **December 2027**. ## C. Commercialization Timeline * **Subsidiary Revenue Onset:** First revenues from subsidiary expected in **FY 2027**, with **binder commercialization slated for H2 FY 2027** post-qualification. ## D. Growth Recovery Assumptions * **Profitability Recovery:** Improved margins anticipated in coming quarters as **seasonal demand rebounds** and **refrigerant volumes rise**. * **Resilient Outlook:** Business fundamentals remain intact; management maintains confidence in long-term trajectory despite near-term pressures.